The overdose reversal drug has been administered mostly by emergency responders and outreach workers. If the agency approves a nonprescription version, it could become as easily available as aspirin.
Category: Food and Drug Administration
-
Eye Drops Linked to One Death and Vision Loss Among Some Are Recalled
The maker of EzriCare Artificial Tears said it was recalling the eye drops after U.S. health authorities linked the product to a drug-resistant bacteria strain.
-
FDA Seeks More Authority to Oversee CBD Products
The agency wants Congress to intervene, saying it does not have adequate oversight powers to ensure the safety of the myriad cannabidiol products derived from hemp.
-
How Do Heavy Metals Like Lead Get in Baby Food?
The problem begins at the farm where plants draw toxins from the soil. There’s no washing them away.
-
New Lawsuit Challenges State Bans on Abortion Pills
The case, brought by GenBioPro, a company that makes one of two abortion drugs, argues that it is unconstitutional for a state to bar access to a medication approved by the federal government.
-
F.D.A. Proposes Limits for Lead in Baby Food
The agency estimated that the guidelines could reduce young children’s dietary exposure to lead by about 25 percent.
-
F.D.A. Outlines a Plan for Annual Covid Boosters
In advance of a scientific meeting on Thursday, officials proposed offering new shots to Americans each fall, a strategy long employed against the flu.
-
The Father of the Abortion Pill
The 96-year-old scientist who came up with an idea for an “unpregnancy pill” decades ago has led an eventful life, from his teenage days in the French Resistance to his friendships with famous artists.
-
No Increased Stroke Risk Linked to Pfizer’s Covid Boosters, Federal Officials Say
An uptick hinted at in surveillance data was a mirage, the officials said.
-
R.J. Reynolds Pivots to New Cigarette Pitches as Flavor Ban Takes Effect
Now that California’s tobacco prohibitions are in place, some Camel and Newport items are billed as newly “fresh” or “crisp” non-menthol versions.
-
SEC Fines Steve Easterbrook, McDonald’s Ex-CEO
The Securities and Exchange Commission fined Steve Easterbrook for lack of disclosure about the circumstances behind his firing in 2019.
-
F.D.A. Approves New Treatment for Early Alzheimer’s
The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other available treatments.